| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3210188 | Journal of the American Academy of Dermatology | 2006 | 13 Pages |
BackgroundDespite efforts to promote sun protection behaviors, melanoma incidence continues to increase. The prognosis of advanced melanoma remains extremely poor in spite of treatment advances, emphasizing the importance of exploring additional preventive measures.ObjectiveWe sought to summarize the results of published research on candidate chemoprevention agents for melanoma.MethodsWe conducted a narrative review of the literature.ResultsInvestigation into a possible role in melanoma chemoprevention continues for multiple agents, including sunscreen, lipid-lowering medications, nonsteroidal anti-inflammatory drugs, dietary nutrients, immunomodulators, and other drugs, including retinoids, difluoromethylornithine, and T4 endonuclease V.LimitationsSystematic review of the literature was not performed.ConclusionBecause no agent yet emerges as a clear choice for effective melanoma chemoprevention, sun avoidance and sun protection remain the mainstay of melanoma prevention for persons at high risk.
